piracetam has been researched along with Autism in 8 studies
Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Therefore, it was of interest to assess the efficacy of piracetam, a positive modulator of AMPA-sensitive glutamate receptors in autistic disorder." | 9.13 | A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder. ( Akhondzadeh, S; Ghelichnia, HA; Mohammadi, M; Mohammadi, MR; Nouroozinejad, GH; Shabstari, OL; Tajdar, H, 2008) |
| "The purpose of this study was to determine the safety and efficacy of the anticonvulsant levetiracetam in the treatment of children with autism." | 7.73 | Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study. ( Anagnostou, E; Chaplin, WF; Hollander, E; Iyengar, R; Soorya, L; Waldoks, SE; Wasserman, S; Watner, D, 2006) |
| " Therefore, it was of interest to assess the efficacy of piracetam, a positive modulator of AMPA-sensitive glutamate receptors in autistic disorder." | 5.13 | A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder. ( Akhondzadeh, S; Ghelichnia, HA; Mohammadi, M; Mohammadi, MR; Nouroozinejad, GH; Shabstari, OL; Tajdar, H, 2008) |
| "The objectives of this study were to determine whether autistic children taking levetiracetam (1) showed improvement in the areas of aggression, impulsivity, hyperkinesis, and mood instability, and (2) showed a nootropic response." | 5.10 | Levetiracetam in autistic children: an open-label study. ( Rugino, TA; Samsock, TC, 2002) |
| "The purpose of this study was to determine the safety and efficacy of the anticonvulsant levetiracetam in the treatment of children with autism." | 3.73 | Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study. ( Anagnostou, E; Chaplin, WF; Hollander, E; Iyengar, R; Soorya, L; Waldoks, SE; Wasserman, S; Watner, D, 2006) |
| "Autism is a pervasive developmental disorder, with impairments in reciprocal social interaction and verbal and nonverbal communication." | 2.74 | First preliminary results of an observation of Panax ginseng treatment in patients with autistic disorder. ( Niederhofer, H, 2009) |
| "Levetiracetam is a commonly prescribed antiepileptic drug, and is generally well tolerated, but can eventually cause behavioral disturbances." | 1.38 | Levetiracetam-induced reversible autistic regression. ( Camacho, A; Espín, JC; Nuñez, N; Simón, R, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niederhofer, H | 1 |
| Camacho, A | 1 |
| Espín, JC | 1 |
| Nuñez, N | 1 |
| Simón, R | 1 |
| Almeida, DM | 1 |
| Jean, MR | 1 |
| Chystsiakova, A | 1 |
| Monahan, E | 1 |
| Oliveira, SB | 1 |
| Monteiro, IM | 1 |
| Rugino, TA | 1 |
| Samsock, TC | 1 |
| Wasserman, S | 1 |
| Iyengar, R | 1 |
| Chaplin, WF | 1 |
| Watner, D | 1 |
| Waldoks, SE | 1 |
| Anagnostou, E | 1 |
| Soorya, L | 1 |
| Hollander, E | 1 |
| Akhondzadeh, S | 1 |
| Tajdar, H | 1 |
| Mohammadi, MR | 1 |
| Mohammadi, M | 1 |
| Nouroozinejad, GH | 1 |
| Shabstari, OL | 1 |
| Ghelichnia, HA | 1 |
| Gualtieri, CT | 1 |
| Golden, RN | 1 |
| Fahs, JJ | 1 |
| Paczynski, M | 1 |
1 review available for piracetam and Autism
| Article | Year |
|---|---|
New developments in pediatric psychopharmacology.
Topics: Adolescent; Adult; Aggression; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Autistic Disorder | 1983 |
4 trials available for piracetam and Autism
| Article | Year |
|---|---|
First preliminary results of an observation of Panax ginseng treatment in patients with autistic disorder.
Topics: Adolescent; Adult; Autistic Disorder; Communication; Humans; Interpersonal Relations; Male; Nootropi | 2009 |
Levetiracetam in autistic children: an open-label study.
Topics: Aggression; Anticonvulsants; Autistic Disorder; Cetirizine; Child; Child Behavior Disorders; Child, | 2002 |
A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.
Topics: Antipsychotic Agents; Autistic Disorder; Child; Child, Preschool; Diagnostic and Statistical Manual | 2008 |
New developments in pediatric psychopharmacology.
Topics: Adolescent; Adult; Aggression; Anorexia Nervosa; Antidepressive Agents, Tricyclic; Autistic Disorder | 1983 |
4 other studies available for piracetam and Autism
| Article | Year |
|---|---|
Levetiracetam-induced reversible autistic regression.
Topics: Anticonvulsants; Autistic Disorder; Cerebral Palsy; Child; Cognition Disorders; Epilepsy; Female; Hu | 2012 |
Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report.
Topics: Acute Disease; Adolescent; Anticonvulsants; Autistic Disorder; Epilepsy; Humans; Levetiracetam; Male | 2013 |
Levetiracetam versus placebo in childhood and adolescent autism: a double-blind placebo-controlled study.
Topics: Adolescent; Adolescent Behavior; Anticonvulsants; Autistic Disorder; Child; Child Behavior; Child, P | 2006 |
Piracetam: a novel therapy for autism?
Topics: Autistic Disorder; Cognition; Humans; Nootropic Agents; Piracetam | 1997 |